Richard Tillyer, PhD

Global Head, Discovery, Product Development & Supply, Johnson & Johnson Innovative Medicine


Developing Patient-Focused Solutions: How a Multi-Modality Approach to Drug Discovery and Development is Driving Transformative Innovation

When considering factors like disease biology and patient needs in drug discovery and development, the goal is to deliver effective and scalable treatments globally by balancing established approaches like small molecules or protein therapeutics with more complex modalities such as RNA, cell, and gene therapies.